# S3AC: Stabilized, Selective, and Scalable Actor-Critic for LLM Reasoning

Preprint · Shuo Shen, Guangran Cheng, Chengqi Lyu, Xiangsen Wang, Yanan Sun, Wenwei Zhang

- Archive id: arxiv:2610.35518
- Published: 2026-10-26
- arXiv: https://arxiv.org/abs/2610.35518
- Citations: 0
- Source URL: https://arxiv.org/abs/2610.35518
- PDF: https://arxiv.org/pdf/2610.35518
- Provenance: arxiv

## Abstract

Critic-free methods are widely used in reinforcement learning with verifiable rewards (RLVR) for long chain-of-thought (CoT) reasoning, avoiding difficult and costly critic training. Common alternatives lack token-level credit assignment and typically rely on grouped rollouts to estimate prompt-specific baselines. A critic can address both limitations, but long-CoT critic training is hindered by insufficient coverage of trajectories with diverse lengths and early gradients dominated by the newly initialized value head. We introduce S3AC (Stabilized, Selective, and Scalable Actor-Critic) for LLM reasoning, built around a practical critic-training recipe. The trained critic provides token-specific advantages and prompt-specific baselines. Using the prompt-level baseline to estimate difficulty, we propose Difficulty-Aware Prompt Sampling (DAPS). DAPS combines this estimate with outcome history to select prompts before generation, reducing rollout waste without offline difficulty initialization. S3AC improves group-rollout performance across dense and mixture-of-experts models from 1.5B to 397B parameters, outperforming a modern GRPO variant (GRPO-X). At 35B, it sustains single-rollout training while tested critic-free baselines deteriorate after initial gains.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Reasoning Models & Test-Time Compute](https://space-kitty.com/topics/reasoning-models)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.